Wonderful Grand Rounds this morning! 🌟
Dr. Vlado Perkovic from the University of New South Wales as our Visiting Faculty Member at Mayo Clinic!
An outstanding presentation on “Progress in Diabetic Kidney Disease”
@VladoPerkovic
1/ How common is antiphospholipid syndrome (APS)?
The answer is more complicated than it seems.
In our new Nature Reviews Rheumatology review, we examine why defining the true epidemiologic burden of APS remains challenging.
Full paper here👉: https://t.co/VhlWosyLKT
Congratulations to an excellent GN conference @LadanZand@LeticiaRolonMD@fervenzaf
Thoroughly enjoyed the discussion.
Thank you for the wonderful hospitality 🙏
Ending our @MayoClinicNeph GN course with Dr. @AleksandraKukl9 sharing her wisdom on New Therapeutic Frontiers in Diabetic Nephropathy. Time to redefine & reclassify common kidney diseases using omics & imaging integration. Agreed that the future of nephrology is bright!
Day 2 of @MayoClinicNeph 2026 Selected Topics in Glomerular Diseases & Kidney Pathology starting off with our fearless leader, Dr. Vesna Garovic, sharing opening remarks highlighting the impact of Mayo Clinic in the field of Nephrology, as well as upcoming courses. Stay tuned!
Wrapping up the day with a discussion on Diabetic Nephropathy, the most common glomerular disease in the world. Started the session with Dr. Alessia Buglioni reviewing Nephropathology of Diabetes and it’s Sweet Surprises @MayoClinicNeph
An amazing two days at @MayoClinicNeph Mayo Clinic’s Selected Topics in Glomerular Diseases and Kidney Pathology 2026 in Rochester!
Great discussions on IgA nephropathy, lupus nephritis, C3GN/MPGN, vasculitis, podocytopathies, diabetic kidney disease, and glomerular disease in pregnancy, alongside genetic testing and kidney pathology.
The case discussions were a highlight—connecting biopsy findings with clinical decisions and bringing together perspectives from nephrology, renal pathology, rheumatology, and hematology.
Many thanks to Drs. Zand @LadanZand , Rolon @LeticiaRolonMD , and Fervenza @fervenzaf for organizing this excellent congress, and to all the faculty for sharing their knowledge and experience @SethiRenalPath@AliDuarteMD@GlassockJ@MPAlexanderMD@GarovicVesna@MayoClinic
#MayoClinic #Nephrology #GlomerularDiseases
Getting to learn from Hematologist, Dr. Meera Sridharan, about TMA and the kidneys with an emphasis on complement-mediated vs. secondary TMA, as well as management approaches, including after transplant! @MayoClinicNeph
The inaugural @MayoClinicNeph Glomerular Diseases & Kidney Pathology course is off to an exciting start! With over 1500 patients in our GN program and >500 new glomerular consults per year, as well as >9000 kidney biopsies read by our kidney pathology colleagues per year…
Dr. Mireille El Ters now helping us open our session on Paraproteins/TMA by introducing Dr. Nelson Leung, a giant in the field helping to guide and create the body of evidence of How Monoclonal Proteins Impact the Kidney @MayoClinicNeph#Onconeph
Dr. Vesna Garovic back on the podium to guide us on the Management Challenges and the Role of Kidney Biopsy for Glomerulonephritis in Pregnancy. Beautiful presentation depicting the common sources of dilemmas and emerging solutions @MayoClinicNeph
Starting our afternoon session with a very important topic: Pregnancy Discussion and Planning in Patients with Glomerular Diseases given by our @MayoClinicNeph expert in women’s health, Dr. Andrea Kattah.
Continuing our all-star lineup, Dr. @GlassockJ discussing Treatment Approaches to Patients with Primary Podocytopathies with a proposal for a serologically guided algorithm to therapy @MayoClinicNeph
For our Podocytopathies session, we have Dr. Paola Romagnani @PRomagnani joining us from the University of Florence in Italy to discuss What is New in the Pathology & Pathogenesis of Podocytopathy @MayoClinicNeph
Back to the podium is Dr. @fervenzaf sharing Advances in Management of Patients with MN. We’ve come a long way with antigen discovery and the prospect of antigen-driven management and now with new therapies in the horizon…@MayoClinicNeph Selected Topics in GN
Kicking off our Membranous Nephropathy session is the one and only @SethiRenalPath showing that MN is no longer a black box and though there is ongoing antigen discovery, serum antigen testing must become available @MayoClinicNeph